Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sebastian Fussek"'
Autor:
Johannes Linxweiler, Bernd Wullich, Katerina Urbanova, Matthias Saar, Laura Bellut, Glen Kristiansen, Angelika Borkowetz, Sebastian Fussek
Publikováno v:
Urol Int
Introduction: Multiparametric MRI (mpMRI) and MRI targeted biopsies (MRtb) are a new standard in prostate cancer (PCa) screening and diagnosis. Guidelines already include this approach for patients at risk. We aimed to gather information from German
Autor:
Nils Kroeger, Sebastian Fussek, J. Huang, Sandra Leisz, Arie S. Belldegrun, Barbara Seliger, D. Brandstetter, B. Dougall, Allan J. Pantuck, Behdokht Nowroozizadeh, Martin Burchardt, André Steven
Publikováno v:
Urologic oncology. 36(11)
Inhibition of the receptor activator of NF-κB ligand (RANKL) has become a standard of care supportive treatment to prevent skeletal related events in cancer patients. Moreover, RANKL inhibition has been implicated with better survival outcome in lun
Autor:
Sebastian Fussek, Alexandra Drakaki, Adrian Bot, Nils Kroeger, Izak Faiena, Stephanie H. Astrow, Rajul K. Jain
Publikováno v:
Journal of Urology. 197
Autor:
Sebastian Fussek, Stefan Oswald, Melanie Preuß, Uwe Zimmermann, Madeleine Saupe, Lisa Rauschenberger, Cornelius Knabbe, Matthias B. Stope, Martin Burchardt, Reinhard Walther
Publikováno v:
World journal of urology. 33(10)
The development of a drug-resistant phenotype is the major challenge during treatment of castration-resistant prostate cancer (PC). In solid cancer entities, one of the major contributors to chemoresistance is the multidrug resistance 1 (MDR1) protei